Comparative study between the effect of methotrexate and valproic acid on solid Ehrlich tumour

Silva, 2006, Sunflower seed oil-enriched product can inhibit Ehrlich solid tumor growth in mice, Chemotherapy, 52, 91, 10.1159/000091308 Sakai, 2010, Translocator protein (18kDa) mediates the pro-growth effects of diazepam on Ehrlich tumor cells in vivo, Eur J Pharmacol, 626, 131, 10.1016/j.ejphar.2009.09.036 Mol, 2008, Current evidence on surgery, systemic MTX and expectant management in the treatment of tubal ectopic pregnancy: a systematic review and meta-analysis”, Hum Reprod Update, 14, 309, 10.1093/humupd/dmn012 Johnston, 2005, The anti-inflammatory action of MTX is not mediated by lymphocyte apoptosis, but by the suppression of activation and adhesion molecules, Clin Immunol, 114, 154, 10.1016/j.clim.2004.09.001 Perucca, 2002, Pharmacological and therapeutic properties of valproate: a summary after 35years of clinical experience, CNS Drugs, 16, 695, 10.2165/00023210-200216100-00004 Sagot-Lerolle, 2008, Prolonged valproic acid treatment does not reduce the size of latent HIV reservoir, AIDS, 22, 1125, 10.1097/QAD.0b013e3282fd6ddc Blaheta, 2005, Evolving anticancer drug valproic acid: insights into the mechanism and clinical studies, Med Res Rev, 25, 383, 10.1002/med.20027 Srikanth, 2002, Enhanced regression of tumours in mice with combined chemotherapy & immunotherapy, Indian J Pharmacol, 34, 172 Basselin, 2008, Chronic administration of valproic acid reduces brain NMDA signaling via arachidonic acid in unanesthetized rats, Neurochem Res, 33, 2229, 10.1007/s11064-008-9700-2 Osman, 1993, Hyperthermic potentiation of cisplatin on solid Ehrlich carcinoma, Tumouri, 79, 268, 10.1177/030089169307900408 Attia, 1966, Immunology of spontaneous mammary carcinomas in mice infected with mammary tumour virus, Cancer Res, 26, 1787 Higgins, 1978, Polymorpho-nuclear leukocyte species differences in the disposal of hydrogen peroxide (H2O2), Proc Soc Exp Biol Med, 158, 478, 10.3181/00379727-158-40230 Uchiyama, 1979, Determination of malondialdehyde precursor in tissues by thiobarbituric acid test, Anal Biochem, 86, 271, 10.1016/0003-2697(78)90342-1 Manso, 1958, Glutathione reductase activity in blood and body fluids, J Clin Invest, 37, 214, 10.1172/JCI103600 Richmond, 1973, Preparation and properties of a cholesterol oxidase from Nocardia and its application to the enzymatic assay of total cholesterol in serum, Clin Chem, 19, 1350, 10.1093/clinchem/19.12.1350 Sarraf, 1988, Kinetic studies on murine sarcoma and an analysis of apoptosis, Br J Cancer, 54, 989, 10.1038/bjc.1986.271 Manne, 1998, Nuclear accumulation of p53 in colorectal adenocarcinomas: prognostic importance differs with race and location of tumour, Cancer, 83, 2456, 10.1002/(SICI)1097-0142(19981215)83:12<2456::AID-CNCR8>3.0.CO;2-5 Ozaslan, 2011, Ehrlich ascites carcinoma, Afr J Biotechnol, 10, 2375 Segura, 2001, Ehrlich ascites tumor cells expressing anti-sense glutaminase RNA lose their capacity to evade the mouse immune system, Int J Cancer, 91, 379, 10.1002/1097-0215(200002)9999:9999<::AID-IJC1046>3.3.CO;2-C Badr El-Din, 2004, Protective role of sanumgerman against γ-irradiation–induced oxidative stress in Ehrlich carcinoma-bearing mice, Nutr Res, 24, 271, 10.1016/j.nutres.2003.11.003 Zahran, 2008, Design, synthesis and antitumor evaluation of novel thalidomide dithiocarbamate and dithioate analogs against Ehrlich ascites carcinoma-induced solid tumor in Swiss albino mice, Bioorg Med Chem, 16, 9708, 10.1016/j.bmc.2008.09.071 Matés, 2008, Intracellular redox status and oxidative stress: implications for cell proliferation, apoptosis, and carcinogenesis, Arch Toxicol, 82, 273, 10.1007/s00204-008-0304-z Sarkar, 1998, Effect of cadmium on glutathione metabolism and glucose 6-phosphate dehydrogenase in rat tissues: role of vitamin E and selenium, Trace Elem Electrolytes, 15, 101 Takahashi, 2007, The antitumour activities of statins, Curr Oncol, 14, 246, 10.3747/co.2007.159 Luo, 2004, Inhibition of NF-κB in cancer cells converts inflammation-induced tumor growth mediated by TNF-α to TRAIL-mediated tumor regression, Cancer cell, 6, 297, 10.1016/j.ccr.2004.08.012 Waterston, 2004, TNF and cancer: good or bad?, Cancer Ther, 2, 131 Ravi, 2002, Interaction of dihydrofolate reductase with MTX: ensemble and single-molecule kinetics, Proc Natl Acad Sci, 99, 13481, 10.1073/pnas.172501499 Basak, 2009, Methotrexate-induced apoptosis is enhanced by altered expression of methylene tetrahydrofolate reductase, Anti-Cancer Drugs, 20, 787, 10.1097/CAD.0b013e32832f4aa8 Winter-Vann, 2003, Targeting Ras signaling through inhibition of carboxyl methylation: an unexpected property of methotrexate, PNAS, 100, 6234, 10.1073/pnas.1135239100 Sung, 2000, Methotrexate suppresses the interleukin-6 induced generation of reactive oxygen species in the synoviocytes of rheumatoid arthritis, Immunopharmacology, 47, 35, 10.1016/S0162-3109(99)00185-X Cutolo, 2001, Anti-inflammatory mechanisms of methotrexate in rheumatoid arthritis, Ann Rheum Dis, 60, 729, 10.1136/ard.60.8.729 Schnyder B, Drexel J, Sauter C. Influence of cyclophosphamide, methotrexate, and 5-fluorouracil on serum cholesterol (Meeting abstract). ASCO Annual Meeting 1996; No. 312. Glozak, 2007, Histone deacetylases and cancer, Oncogene, 26, 5420, 10.1038/sj.onc.1210610 Cinatl, 2002, Induction of differentiation and suppression of malignant phenotype of human neuroblastoma BE(2)-C cells by valproic acid: enhancement by combination with interferon-alpha, Int J Oncol, 20, 97 Fourcade, 2010, Valproic acid induces antioxidant effects in X-linked adrenoleukodystrophy, Hum Mol Genet, 19, 2005, 10.1093/hmg/ddq082 Glauben, 2006, Histone hyperacetylation is associated with amelioration of experimental colitis in mice, J Immunol, 176, 5015, 10.4049/jimmunol.176.8.5015 Zhang, 2008, Valproic acid attenuates inflammation in experimental autoimmune neuritis, Cell Mol Life Sci, 65, 4055, 10.1007/s00018-008-8521-4 Zgouras, 2004, Modulation of angiogenesis-related protein synthesis by valproic acid, Biochem Biophys Res Commun, 316, 693, 10.1016/j.bbrc.2004.02.105 Gurvich, 2004, Histone deacetylase is a target of valproic acidmediated cellular differentiation, Cancer Res, 64, 1079, 10.1158/0008-5472.CAN-03-0799 Beger, 2009, Single valproic acid treatment inhibits glycogen and RNA ribose turnover while disrupting glucose-derived cholesterol synthesis in liver as revealed by the [U-13C6]-d-glucose tracer in mice, Metabolomics, 5, 336, 10.1007/s11306-009-0159-1 Pipalia, 2011, Histone deacetylase inhibitor treatment dramatically reduces cholesterol accumulation in Niemann–Pick type C1 mutant human fibroblasts, PNAS, 108, 5620, 10.1073/pnas.1014890108